Tag: PE
Penumbra announces FDA clearance of Lightning Flash 2 for the treatment...
Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Flash 2, the next generation computer assisted vacuum thrombectomy (CAVT)...
FDA clears AI-driven detection tool for pulmonary embolism
Medical imaging AI company Avicenna.AI has announced 510(k) clearance from the US Food and Drug Administration (FDA) for its CINA-iPE artificial intelligence (AI)-powered tool that...
Study provides insights from US cohort of FLASH registry for high-risk...
New research from the FLASH registry shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism. The study, titled "Mechanical thrombectomy for high-risk pulmonary embolism:...
Akura thrombectomy system for PE appears safe and demonstrates reduction of...
Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at...
FLAME, FLASH and ongoing PEERLESS trials collect “compelling” data for FlowTriever...
Speaking on the FLAME, FLASH and PEERLESS trials that each collected data on the FlowTriever (Inari Medical) device for the treatment of pulmonary embolism...
New study demonstrates IVC filters “safe and effective” in treating venous...
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
New mechanical thrombectomy systems unlock possibilities for the treatment of venous...
Gerd Grözinger (Tübingen, Germany) chats with Bernhard Gebauer (Berlin, Germany) at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14...
Viz.ai launches AI-powered modules for pulmonary embolism and aortic disease
Viz.ai has announced the US commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Debuting at VEITHsymposium 2021 (16–20 November, Orlando, USA), the...
Viz.ai and Avicenna.AI partner to launch AI-driven intelligent care coordination for...
Viz.ai has partnered with Avicenna.AI to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE) and aortic disease.
Avicenna.AI’s US...
AI triage solution for PE and aortic dissection receives FDA clearance...
Medical imaging artificial intelligence (AI) specialist Avicenna.AI recently announced that it has received certification in the USA and European Union (EU) for CINA CHEST,...
ILLUMENATE four-year pooled analysis has “brought increased clarity” to the paclitaxel...
Sean Lyden (Cleveland, USA), current VIVA Board president, speaks to Vascular News about his two years at the helm, which began with the “controversy on...
“Competing safety profiles” of PE devices muddies decision-making
“There has been a steady change in the approach and care of pulmonary embolisms that has been noted over the last five to seven...
Thrombus dissolution with EKOS™ Acoustic Pulse Thrombolysis™ in everyday clinical practice
At the EKOS symposium at LINC 2019, Nils Kucher (Zurich, Switzerland), Houman Jalaie (Aachen, Germany) and Mert Dumantepe (Istanbul, Turkey) share their experiences in...
